Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Restructuring Costs: 2023-2024

Historic Restructuring Costs for Maravai Lifesciences Holdings (MRVI) over the last 2 years, with Dec 2024 value amounting to -$1.2 million.

  • Maravai Lifesciences Holdings' Restructuring Costs rose 184750.00% to $7.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.4 million, marking a year-over-year increase of 40.75%. This contributed to the annual value of -$1.2 million for FY2024, which is 118.78% down from last year.
  • As of FY2024, Maravai Lifesciences Holdings' Restructuring Costs stood at -$1.2 million, which was down 118.78% from $6.5 million recorded in FY2023.
  • In the past 5 years, Maravai Lifesciences Holdings' Restructuring Costs ranged from a high of $6.5 million in FY2023 and a low of -$1.2 million during FY2024.
  • Its 2-year average for Restructuring Costs is $2.6 million, with a median of $2.6 million in 2023.
  • Data for Maravai Lifesciences Holdings' Restructuring Costs shows a maximum YoY slumped of 118.78% (in 2024) over the last 5 years.
  • Maravai Lifesciences Holdings' Restructuring Costs (Yearly) stood at $6.5 million in 2023, then crashed by 118.78% to -$1.2 million in 2024.